1. Home
  2. HCVI vs CBUS Comparison

HCVI vs CBUS Comparison

Compare HCVI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCVI
  • CBUS
  • Stock Information
  • Founded
  • HCVI 2021
  • CBUS 2010
  • Country
  • HCVI United States
  • CBUS United States
  • Employees
  • HCVI N/A
  • CBUS N/A
  • Industry
  • HCVI Blank Checks
  • CBUS Agricultural Chemicals
  • Sector
  • HCVI Finance
  • CBUS Industrials
  • Exchange
  • HCVI Nasdaq
  • CBUS Nasdaq
  • Market Cap
  • HCVI 176.6M
  • CBUS 160.8M
  • IPO Year
  • HCVI 2021
  • CBUS 2017
  • Fundamental
  • Price
  • HCVI $10.66
  • CBUS $5.25
  • Analyst Decision
  • HCVI
  • CBUS Strong Buy
  • Analyst Count
  • HCVI 0
  • CBUS 3
  • Target Price
  • HCVI N/A
  • CBUS $23.67
  • AVG Volume (30 Days)
  • HCVI 31.1K
  • CBUS 129.6K
  • Earning Date
  • HCVI 01-01-0001
  • CBUS 08-08-2024
  • Dividend Yield
  • HCVI N/A
  • CBUS N/A
  • EPS Growth
  • HCVI N/A
  • CBUS N/A
  • EPS
  • HCVI N/A
  • CBUS N/A
  • Revenue
  • HCVI N/A
  • CBUS $2,961,000.00
  • Revenue This Year
  • HCVI N/A
  • CBUS $36.93
  • Revenue Next Year
  • HCVI N/A
  • CBUS $236.45
  • P/E Ratio
  • HCVI N/A
  • CBUS N/A
  • Revenue Growth
  • HCVI N/A
  • CBUS 816.72
  • 52 Week Low
  • HCVI $10.30
  • CBUS $4.26
  • 52 Week High
  • HCVI $11.47
  • CBUS $23.18
  • Technical
  • Relative Strength Index (RSI)
  • HCVI 60.14
  • CBUS 33.11
  • Support Level
  • HCVI $10.62
  • CBUS $4.26
  • Resistance Level
  • HCVI $10.66
  • CBUS $7.49
  • Average True Range (ATR)
  • HCVI 0.01
  • CBUS 0.67
  • MACD
  • HCVI -0.00
  • CBUS -0.13
  • Stochastic Oscillator
  • HCVI 100.00
  • CBUS 26.61

About HCVI Hennessy Capital Investment Corp. VI

Hennessy Capital Investment Corp VI is a shell company.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: